[EN] SUBSTITUTED ACETYLENE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4<br/>[FR] DÉRIVÉS D'ACÉTYLÈNE SUBSTITUÉS ET LEUR UTILISATION À TITRE DE MODULATEURS ALLOSTÉRIQUES POSITIFS DU MGLUR4
申请人:MERCK PATENT GMBH
公开号:WO2014121883A1
公开(公告)日:2014-08-14
The present invention relates to novel acetylene derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
Bicyclic pyridinylpyrazoles of the formula (I)
in which the symbols have the meanings given in the description and agrochemically active salts thereof and their use for controlling unwanted microorganisms in crop protection and the protection of materials and for reducing mycotoxins in plants and plant parts, and also processes for preparing compounds of the formula (I).
Photoluminescent properties and crystal structure of a metal-perturbed donor–acceptor acetylene complex
作者:Xiao Hong、Hon-Kay Yip、Kung-Kai Cheung、Chi-Ming Che
DOI:10.1039/dt9930000815
日期:——
intraligand 3(ππ*) and 3(dπ*)(dσ*) excited states has been observed in fluid solution and the solid state of [Pt2(dppm)2Cl(L)]ClO4[dppm = Ph2PCH2PPh2, L =(4-chlorophenyl)(4-pyridyl)-acetylene], the structure of which has been determined by X-ray crystallography.
2-Phenyl-1,3-di(4-pyridyl)naphthvalene 3a was synthesized by the photoinduced reversible valence isomerization of 2-phenyl-1,3-di(4-pyridyl)naphthalene 2a. Then, 3a was converted into 3-phenyl-1,2-di(4-pyridyl)naphthalene 4a and 2a simultaneously. The t1/2 of 3a in DMSO-d6 at 90 °C was 2 h, while that at 110 °C was approximately 10 min.
2-苯基-1,3-二(4-吡啶基)naphthvalene 3A通过2-苯基-1,3-二(4-吡啶基)萘的光致可逆价异构合成2a中。然后,将3a同时转化为3-苯基-1,2-二(4-吡啶基)萘4a和2a。在90°C下DMSO- d 6中3a的t 1/2为2 h,而在110°C下约为10分钟。
Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4
申请人:MERCK PATENT GMBH
公开号:US20150376182A1
公开(公告)日:2015-12-31
The present invention relates to novel acetylene derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.